Get the Stockscreener App
0.5108
2.91%
-0.0153
After Hours:
.50
-0.0108
-2.11%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Prophase Labs Inc stock is traded at $0.5108, with a volume of 545.15K.
It is down -2.91% in the last 24 hours and up +17.83% over the past month.
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
See More
Previous Close:
$0.5261
Open:
$0.5235
24h Volume:
545.15K
Relative Volume:
0.09
Market Cap:
$21.22M
Revenue:
$62.71M
Net Income/Loss:
$-10.48M
P/E Ratio:
-0.8108
EPS:
-0.63
Net Cash Flow:
$-13.77M
1W Performance:
-14.18%
1M Performance:
+17.83%
6M Performance:
+65.58%
1Y Performance:
-78.80%
1-Day Range:
$0.507
$0.5407
1-Week Range:
$0.4783
$0.6659
52-Week Range:
$0.2179
$2.4999
Prophase Labs Inc Stock (PRPH) Company Profile
Name
Prophase Labs Inc
Sector
Industry
Phone
(215) 345-0919
Address
711 STEWART AVE, SUITE 200, NEW YORK, PA
Compare PRPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.5108 | 21.85M | 62.71M | -10.48M | -13.77M | -0.63 |
|
TMO
Thermo Fisher Scientific Inc
|
524.58 | 198.17B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
205.14 | 144.97B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
633.32 | 49.29B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
138.23 | 38.73B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
203.77 | 33.69B | 15.70B | 1.24B | 2.01B | 6.9036 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-21 | Initiated | H.C. Wainwright | Buy |
| Oct-13-21 | Downgrade | Dawson James | Buy → Neutral |
| Jan-20-21 | Initiated | Dawson James | Buy |
Prophase Labs Inc Stock (PRPH) Latest News
What data driven models say about ProPhase Labs Inc.’s futureSell Signal & Reliable Price Action Trade Plans - newser.com
Key resistance and support levels for ProPhase Labs Inc.Trade Volume Report & Real-Time Buy Zone Alerts - newser.com
Why analysts upgrade ProPhase Labs Inc. stockWeekly Profit Analysis & Expert Curated Trade Setup Alerts - newser.com
Volume spikes in ProPhase Labs Inc. stock – what they mean2025 Market Sentiment & Fast Moving Trade Plans - newser.com
Exit strategy if you’re trapped in ProPhase Labs Inc.July 2025 Technicals & Fast Exit Strategy with Risk Control - newser.com
What analyst consensus says on ProPhase Labs Inc. stockVolume Spike & Technical Confirmation Trade Alerts - newser.com
Using economic indicators to assess ProPhase Labs Inc. potentialMarket Activity Report & Free Fast Gain Swing Trade Alerts - newser.com
Published on: 2025-10-10 04:36:34 - newser.com
Is ProPhase Labs Inc. meeting your algorithmic filter criteriaMarket Performance Summary & Safe Entry Trade Signal Reports - newser.com
Quantitative breakdown of ProPhase Labs Inc. recent moveWeekly Gains Report & Accurate Entry/Exit Alerts - newser.com
What technical models suggest about ProPhase Labs Inc.’s comeback2025 Investor Takeaways & Safe Capital Growth Stock Tips - newser.com
ProPhase Labs Inc. stock outlook for YEARTrade Risk Assessment & Expert Curated Trade Setups - newser.com
Can ProPhase Labs Inc. rally from current levelsPortfolio Gains Report & Proven Capital Preservation Methods - newser.com
Risk adjusted return profile for ProPhase Labs Inc. analyzedWeekly Trend Summary & Fast Moving Trade Plans - newser.com
Tick level data insight on ProPhase Labs Inc. volatilityMarket Performance Recap & Long-Term Safe Return Strategies - newser.com
Published on: 2025-09-29 08:39:17 - newser.com
ProPhase Labs’ COVID-19 testing subsidiaries file for bankruptcy - Investing.com India
Critical Biotech giant files Chapter 11 for 3 COVID labs, eyes Bitcoin treasury as lifeline - TheStreet
ProPhase Labs’ COVID-19 testing subsidiaries file for bankruptcy By Investing.com - Investing.com Canada
ProPhase Labs (PRPH) Files for Chapter 11 Bankruptcy for COVID-1 - GuruFocus
PROPHASE LABS, INC. ANNOUNCES COMPLETION OF IMPORTANT NEXT - GlobeNewswire
$50M Insurance Recovery Target: ProPhase Labs Strategic Bankruptcy Filing Could Net Multiple Returns - Stock Titan
ProPhase Labs explores crypto treasury strategy after shareholder vote By Investing.com - Investing.com Nigeria
ProPhase Continues its Exploration of a Crypto Treasury Strategy - GlobeNewswire
ProPhase Filed for Chapter 11 as $13M Liabilities Collide With Crypto Ambitions - USA Herald
ProPhase Labs explores crypto treasury strategy after shareholder vote - Investing.com India
ProPhase Units Hit Ch. 11 With Plans For Crypto Treasury - Law360
ProPhase Labs (PRPH) Embarks on Strategic Crypto Treasury Plan - GuruFocus
ProPhase Labs explores crypto treasury strategy after shareholder approval By Investing.com - Investing.com South Africa
ProPhase Labs explores crypto treasury strategy after shareholder approval - Investing.com
$50M Medical Collections Expected: ProPhase Labs Advances Crypto Strategy While Developing Cancer Test - Stock Titan
Prophase Labs Inc Stock (PRPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.61%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):